Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

计划入组 646 人 · 首次发布于 2023 年 4 月 14 日

growth factor (Synairgen)

Interferon beta-1a(Avonex, Rebif)

Synairgen Research Ltd.

United Kingdom

Synairgen Research Ltd

Belgium

SYNAIRGEN RESEARCH LIMITED

Spain

Synairgen Advances SNG001 Towards Phase II Trial for COPD

Synairgen Advances to Phase 3 Trial of Inhaled COVID-19 Treatment SNG001

Synairgen Secures £18 Million to Advance Phase 2 Trial of SNG001 in Mechanically Ventilated Patients